DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Dvory-Sobol H, Wyles D, Ouyang W. , et al.
Long-term persistence of HCV NS5A variants after treatment with NS5A inhibitor ledipasvir.
J Hepatol 2015;
62 (Suppl. 02) S221
We do not assume any responsibility for the contents of the web pages of other providers.